Cannabidiol (CBD) helps with inflammation and pain, particularly that which is neurological in nature. CBD is efficacious in treating pain, inflammation, stress, anxiety, and overall well being by modulating pain receptors in the brain.
As of June 2018, the FDA has approved the Epidiolex prescription, a CBD oil without THC, for refractory seizure treatment. Active research is delving into its clinical relevance in more diverse therapeutic applications for psoriasis, Parkinson’s disease, mood disorders, post-traumatic stress disorder (PTSD) insomnia, and cancer prevention. We are pending FDA approval of a CBD-based treatment for Multiple Sclerosis.
In a recent study in 2020, 7,441 cases of CBD usage for migraines found a significant reduction in migraine ratings and even a 50% reduction in migraine severity. The American Migraine Foundation also reports that specific CBD oil is a promising option for migraine treatment.